Goldfarb, 71, chief executive officer of Ruane, Cunniff & Goldfarb and co-manager of the Sequoia Fund, is retiring after the firm’s investment in troubled drugmaker Valeant Pharmaceuticals International Inc. marred the reputation of a mutual fund that traces its roots to billionaire Warren Buffett.